NCT06920745
TriClip CED RWE Study
Recruiting
Not specifiedAges 18+ObservationalAbbott Medical Devices
~2,200 participants
Updated 2025-08-11 on ClinicalTrials.gov
What's tested:The TriClip System
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Composite of heart failure hospitalization or all-cause mortality
Measured over 2 years
Conditions
NCT06920745
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Abbott
Santa Clara, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients ≥ 18 years of age at time of implant
Patients with symptomatic, severe or greater Tricuspid Regurgitation who have received the TriClip system (treatment group) or have not undergone T-TEER (control group)
Exclusion
Patients with less than severe Tricuspid Regurgitation
Patients with a prior history of surgical or transcatheter tricuspid valve replacement
Patients with a surgical or transcatheter aortic or mitral valve intervention within 90 days prior to index
What this trial measures
- Composite of heart failure hospitalization or all-cause mortality2 years
Compare the rate of composite endpoint at 2 years between the treatment and control groups.